Cosmos Health Reaches Rapid Growth Milestone in Online Customer Subscriptions
Chicago, Wednesday, 11 November 2026.
Cosmos Health expanded its online subscription model to an annualized twenty-two million dollars by October 2026, with recurring consumer orders now driving sixty-one percent of total monthly digital sales.
Cosmos Health’s U.S. Subscription Model Achieves $22 Million Annual Run Rate
Cosmos Health Inc. (NASDAQ: COSM) has reported that its U.S. e-commerce division’s subscription model reached an annualized run rate of approximately $22.0 million by the end of October 2026. This milestone was achieved through a monthly subscription value of $1,832,785 as of October 31, 2026, as detailed in the company’s operational update released on November 11, 2026 [1]. The company’s total U.S. e-commerce sales for October 2026 amounted to $1,673,004, with recurring subscriptions accounting for $1,015,231, or 61%, of the total revenue [1].
Rapid Growth in Active Subscribers and Order Volume
Cosmos Health’s U.S. subscription business has demonstrated significant growth, with 12,532 active subscribers as of October 31, 2026, reflecting a net increase of 11,544 subscriptions during the month [1]. The total order volume for October 2026 reached approximately 19,100, driven by 234,500 online store sessions and a conversion rate of 7.72% [1]. The average subscription included approximately 2.4 products per subscriber, highlighting the diversification of the company’s offerings within its direct-to-consumer model [1].
Strategic Shift Toward Recurring Revenue Models
The company’s rapid ascent in subscription-based revenue reflects a broader industry trend among consumer healthcare and wellness companies. Cosmos Health’s leadership has emphasized the strategic importance of recurring revenue models, which are designed to enhance customer lifetime value and improve operating margins [1]. CEO Greg Siokas stated, ‘Since we began scaling our U.S. subscription platform in mid-September, we have built a subscription business with $1.83 million in monthly subscription value, or approximately $22 million on an annualized basis.’ He further noted that recurring revenue is among the most valuable revenue streams a consumer health company can establish [1].
Market Reaction and Analyst Perspectives
Following the announcement, Cosmos Health’s stock price on NASDAQ (COSM) was reported at $0.21 on November 11, 2026, marking a 7.2% increase [3]. Analysts have provided varied perspectives on the company’s future trajectory. Noble Capital Markets initiated coverage on October 26, 2026, with an Outperform rating and a $1.40 price target, while Zacks Small-Cap Research set a higher target of $4.50 based on a discounted cash flow model [4]. The average price target of $2.95 suggests potential upside, though the wide range reflects differing valuation methodologies [4]. Additionally, the RSI Oscillator for COSM moved out of oversold territory on October 27, 2026, historically indicating a 90% probability of upward momentum [4].
Upcoming Corporate Actions and Earnings Announcements
Cosmos Health is poised for a 1-for-20 reverse stock split, with the Certificate of Amendment becoming effective at 4:00 PM local time on November 12, 2026, and the split taking effect on November 13, 2026 [8]. This action follows shareholder approval at an annual meeting on October 1, 2025, and aims to reposition the stock’s valuation profile [8]. Investors are also anticipating the company’s Q3 2026 earnings announcement, scheduled for November 17, 2026, at 7:00 AM ET, with revenue estimates at $17.34 million and expected earnings per share (EPS) at -$0.04 [7].